View
321
Download
0
Category
Preview:
Citation preview
1
Cardiac Failure
Presented by K.Harshitha
2
ContentsDefinitionEtiologyClinical classification of cardiac failurePathophysiologyStages of cardiac failureCauses of cardiac failureMulti system effects of cardiac failureClassification of cardiac drugsMechanism of action of cardiac drugsDrug therapy and TreatmentReferences
3
4
Definition of Cardiac failure Cardiac failure is a physiological state in which the heart cannot pump enough blood to meet the metobolic needs of the body.
• Cardiac failure occurs when the cardiac out put is inadequate to provide the oxygen needed by the body.
•The most common cause of cardiac failure is in Ejection fraction.
5
Ejection fraction:
Etiology Cardiac performance is
depends on four essential components:
PreloadAfter loadContractility of the muscleHeart rate
7
Preload: Volume of blood in ventricles at the end of
diastole
Due to CO Blood volume remains after systole
Stretch of myocardial fibers.But in failed heart Did not response
As heart failure worsens Preload contributes to symptoms
Dyspnoea Hepatic enlargement
8
Afterload: The pressure against which the left ventricle ejects.
Systemic resistance CO
• Afterload is the tension or stress developed in the wall of the left Ventricle during ejection.
9
Contractility of the muscle: It is the force of contraction generated by
the myocardium under loading conditions.
Heart Rate: it is the major determinant of the cardiac
failureAs the function of the heart in failure, an
in heart rate is the first compensatory mechanism.
10
Clinical classification of Cardiac Failure:
According to the position • Backward failure • Forward failure
According to the location of heart failure• Left ventricular failure • right ventricular failure• Biventricular failure(Total Heart failure)
According to the cardiac out put• High output failure • low output failure
According to the function impaired• Systolic failure • Diastolic failure
11
Backward failure : It is the condition of venous congestion arising from the damming of blood behind the failing chamber.
Forward Failure : it is the condition of inadequate perfusion. It results when reduced contractility produces stroke volume and cardiac output.
12
13
Left ventricular failure(Left sided Heart failure) The failure of the left ventricle to maintain adequate
cardiac output.
In LVF basic fault lies in the heart muscles itself . Practically always result from damage to the ventricular myocardium.
Precipitating factors:
• MI• Hypertension• Dysrhythmias
14
Right ventricular failure(Right sided Heart failure)
• Occurs when the right pump fails.• It develop as a result of the stress placed upon the right
ventricle it attempts to pumps blood against resistance into the patient’s congested lungs.
• Causes of right ventricular failurePulmonary diseasesConstrictive pericarditisTricuspid and pulmonic valve disordersInfarction of the right ventricle(rare)
Biventricular failure: LV Failure + RV failure
15
High out put failure: It occurs when the body need excess oxygen. The heart increases out put but is still unable to meet body’s needs.
Low out put failure: It is the condition when the heart
is unable to pump an adequate supply of blood to the body.
• Low output failure results in Hypoperfused tissue cells.
• It occurs when the myocardium is so damaged that it cannot maintain adequate cardiac output.
• Right and left sided cardiac failure are sometimes referred to as low output failure.
16
Systolic failure:Systolic dysfunction or ejection failure is the
inability of the ventricles to pump and empty adequately.
The ventricles are dilated and therefore need to develop higher tension in its walls to eject the blood efficiently.
Diastolic failure:Stiffening and loss of adequate relaxation of the myocardium during diastole.Cardiac out put is reduced but ejection fraction may benormal.
17
Systolic Ventricles cannot pump
Dysfunction effectivelyDiastolic ventricles
cannot relaxDysfunction and fill during
diastole
18
Systolic and diastolic heart compare with normal heart
19
Pathophysiology of cardiac failure:
• Neurohumoral or extrinsic compensation involves two major mechanisms:
The sympathetic nervous systemRenin-angiotensin aldosterone
The most important intrinsic compensatory mechanism is Myocardial Hypertrophy or Ventricular Remodeling.
20
Cardiac failure
Reduced CO Ses cardiac
filling Renin Sympathetic pressure NS activation Angiotension I vasoconstriction Na &
Water Angiotension II
retention
Aldosterone Cardiac remodeling
21
Salt and water retentionDue to CO & RBF RAA
activation(renin angiotensin aldosterone activation)
Angiotensin Sympathetic activationAldosterone Causes salt and water
retention via renal tubulesBoth tries to compensate the low CO & low BPBut it can worsen the venous pressure(preload)More fluid accumulation in the interstitiumWorsens the signs of heart failure
22
Ventricular remodeling:It is the most important intrinsic compensatory
mechanism referred as cardiac remodelingIt is the process of progressive of ventricular
size, shape and function owing to the influence of Mechanical, Neurohumoral and possibly genetic factors in clinical conditions including
• Myocardial infraction• Cardiomyopathy• Hypertension• Valvular heart disease
Hall marks are: Hypertrophy, loss of myocytes and interstitial fibrosis.
23
Ventricular remodeling in diastole &systole
24
Stages of Cardiac Failure: Stage A: A symptomatic with no heart damage but
have risk factors for heart failure.These could include persons with hypertension
diabetes, alcohol abuse, family history of cardiomayopathy.
Stage B: Asymptomatic but have signs of structural heart damage
Patients in this category may have left ventricular hypertrophy, valvular heart disease.
Stage C: Have symptoms and heart damage.Patients exhibit fatigue and dyspnoea as a result
of ventricular dysfunction Stage D: End stage cardiac failure
25
New York Heart Association (NYHA) Classification of cardiac failure
Class-1 No limitation. Normal physical exercise does not cause fatigue,dyspnoea or palpitations
Class-2 Mild limitation. Comfortable at rest but normal physical activity produces fatigue,dyspnoea or palpitations
Class-3 Marked limitation. comfortable at rest but gentle physical activity produces marked symptoms of cardiac failure
Class-4 Symptoms of heart failure occur at rest and are exacerbated by any physical activity.
26
Causes of Cardiac Failure® Dysfunction of myocardium
Myocardial damage Myocardial infraction Cardiomyopthay Myocarditis
Metabolic disturbanceIschemia and HypoxiaBeriberi
27
Causes of cardiac failure cont’d…………….
• Overload of myocardium• Infection like lung infection• Arrhythmia• Tachycardia• Bradycardia• Excessive physical activity• Pregnancy and delivery• Anemia• Alcohol consumption, obesity• Dyslipidemia / Hypercholesterolemia
28
Multisystem effects of cardiac failure:Respiratory system
Dyspnea on exertionShortness of breathTachypneaOrthopneaDry cough
Gastro intestinal Anorexia , nauseaAbdominal distentionLiver enlargementRight upper quadrant pain
29
Multisystem effects of cardiac failure cont’d…….
Musculoskeletal FatigueWeakness
NeurologicConfusionImpaired memoryAnxiety , restlessnessInsomnia
Cardiovascular systemTachycardiaPalpitationsHepatojugular reflux
30
Classification of the drugs:Cardiac Glycosides DigoxinOther positive inotropic drugs
Bipyridines Milrinone Beta adrenergic agonists Dobutamine , Dopamine
Drugs without positive inotropic effects Angiotension converting enzyme inhibitor(ACEI) Captopril ,
Enalapril , Lisinopril Diuretics Furosemide,Thiazide Angiotension II receptor blockers (ARB)
Losartan , Valsartan Vasodilators Hydralazine Beta Blockers Carvedilol , Bisoprolol , Metoprolol
31
Drug Therapy:To increase force of contraction
Digoxin β agonists (dobutamine , dopamine)Bipyridines ( Milrinone)
To reduce cardiac workloadTo decrease preload(Diuretics , nitrates)To decrease afterload (arterial vasodilators)To decrease preload and afterload
(ACEI,ARB) (Nitrates , sodium, nitroprusside)To prolong the survival
β adrenoreceptor blockers
32
Cardiac glycosidesDigoxin is the derivative of digitalis in
current useAll of the cardiac glycosides of which digoxin
is the prototype combine asteroid nucleus Cardiac glycosides are the extract of many
common plants Digitalis purpurea(red foxglove) Digitalis lutea
33
Mechanism of action: Cardiac glycosides
Inhibit Na+ pump in cardiac cells Accumulation of intracellular Na+
Prevents extrusion of Ca+ entry of Ca++ into the cell
Intracellular Ca+ + Stored in sarcoplasmic reticulum
Ca++ released during each contraction force and velocity of contraction
34
Mechanism of action of digoxinIt is the result of 2 step process
SERCA-sarcoplasmic endoplasmic reticulum calcium ATPaseRyR- Ryanodine receptor calcium channel, TnC- Troponin C
35
Pharmacological action of digoxinCardiac effect• At therapeutic dose
Direct FOC of heartIndirect HR may leads to AV block
• At higher concentrationDirect Increase automaticity of heart
Indirect Sympathetic activation Both may lead to ventricular arrhythmias
36
Therapeutic uses of digoxin
Heart failure with atrial fibrillation (use only when diuretics and ACEI have failed to control the symptoms
Mild symptoms Slow loading dose Acute heart failure Rapid
Digitalization
Treatment of atrial arrhythmia( atrial fibrillation & flutter)
37
How digoxin corrects Cardiac FailureDue to FOC CO RBF (relieve
oliguria)Due to better tissue perfusion relieve
CyanosisDue to blockage of AV node , conducting
tissues Slow ventricular rate relieve tachycardia
Due to Co Better emptying of the ventricles increase venous return better drainage from the tissues with relief of congestion in the lungs and liver and reduction of oedema ,relief of dyspnea
Better results are obtained in patients with atrial fibrillation than with normal rhythm
Narrow therapeutic index (safety margin)
38
Why digoxin is used in atrial fibrillation, flutter
In atrial flutter and fibrillation
Digitalis controls the excessive ventricular rate
Improvement is due to direct effect of digitalis as well as the effect of vagus on the SA node and conducting tissue
In atrial fibrillation , Reduction of ventricular rate is the best measure of glycoside effect.
39
Adverse effects of digoxinCNS : Digitalis has little apparent CNS effect in
therapeutic doseHigher doses cause CTZ activation
nausea and vomitingHigher doses produces
Hyperpnoea Visual disturbancesDisorientationMental confusion
40
Adverse effects of digoxin Cont’d…………..
CVS Ventricular arrhythmia Interaction with electrolytes
HypokalaemiaHypercalcaemia
d/t steroid structure gynaecomastia(rare)GIT : Gastrointestinal tract is most
common site of digitalis toxicity outside the heartANVD Anorexia , nausea , vomiting , diarrhea
41
Digitalis ToxicityToxic effects may occur before the
therapeutic end point is detectedSerum digitalis , k+ levels and ECG should
be monitored during therapy of digitalis toxicity
In severe intoxication , serum k+ is already elevated , automaticity is depressed and antiarrhythmic agents may lead to cardiac arrest.
Digitalis antibodies(digoxin immune Fab)
42
Positive inotropic drugs They increase the heart’s ability to pump more
effectively by improving the contractile force of the muscle.
It include selective beta agonists and BipyridinesDobutamine Mechanism of action: selective agonist on cardiac
activity Pharmacological action: Increase Cardiac output(CO)
Most commonly used inotropic agent other than digitalis
Mainly inotropic rather than chronotropic action Route of administration : Given by I.V infusion Adverse effects : cardiac arrhythmia Therapeutic use : used in acute decomposed heart
failure
43
DopamineMechanism of action : Dose related action
D1,β1,α1Pharmacological action: Low dose activate D1
in RBFIntermediate dose activate β1
FOC,HR,CORoute of administration: Given by IV infusionAdverse effects: cardiac arrhythmiaTherapeutic use : used in acute decompensated
cardiac failure
44
Bipyridines(Milrinone)Mechanism of action
• Inhibits phosphodiesterase type 3 enzyme• Decrease cAMP breakdown cAMP FOC of
heartPharmacological action : cause increase FOCRoute of administration ParentralAdverse effects Cardiac arrhythmiaTherapeutic use Acute heart failure or severe exacerbation of chronic heart failure
45
Angiotension converting enzyme inhibitors (ACEI)
Plays a vital role in the management of cardiac failure due to systolic dysfunction . ACEI given in combine with diuretics.
ACE inhibitors promotes vasodilation and diuresis by decreasing afterload and preload
Decrease the secretion of aldosterone a hormone that causes the kidneys to retain sodium and water
Stimulate the kidneys to excrete sodium and fluid thereby reducing left ventricular filling pressure & decreasing pulmonary congestion
Patients receiving ACE inhibitors should be monitored for Hypotension , Hyperkalemia , alteration in renal function
46
ACE Inhibitors : Captoprill,Enalapril,LisinoprilMechanism of action:• Inhibits angiotensin converting enzyme (which converts
angiotensin I to angiotensin II)• Reduce formation of angiotensin II • Angiotension II is the potent vasoconstrictor in body & it
causes production to aldosterone , which causes salt and water retention from kidney.
Pharmacological Action:• ACEI decrease the formation of Ang II and aldosterone• Atrial fibrillation Afterload• Venous dilation preload• Aldosterone action Salt & water retention Vascular volume• Sympathetic activation
47
Diuretics• Eliminate excess body water and decrease
ventricular pressure.• A low sodium diet and fluid restriction
complement this therapy.• Some diuretics may have slight venodilator
properties.• Diuretics are used in chronic heart failure
usually in combination with others.
48
Diuretics (Thiazide)Mechanism of action • Hydrochlorothiazide , chlorthalidone(milder
diuretics) inhibits Na +- Cl _ symport in PCT
(primary convoluted tubule) of nephronsPharmacological action• Mild diuresis action + venodilation action Can
cause salt and water excretion & reduction of preload
Route of administration : given orally Adverse effects : electrolyte imbalance
( especially Hypokalaemia which can worsen digitalis toxicity)
49
Diuretics (Furosemide)Mechanism of action: • Highly potent loop diuretics inhibits Na+-k+-Cl- symport
in loop of Henley of nephrons.Pharmacological action: • Diuresis action + venodilation action + decreases in L.V
filling pressure• Can cause salt and water excretion & reduction of
preloadRoute of administration: available as oral as well as IVTherapeutic use: first choice in acute CHF to relieve
morbidityQuick onset , short durationAdverse effects: Hypotension,dehydration,temporary
deafness (with large doses),Hypokalaemia(offset by k sparing diuretics
50
Angiotension II receptor blockers(ARB)Blocks the effects of Angiotension II at the Ang II
receptorACE inhibitors and ARBs have similar Hemodynamic effects: BP , systemic vascular
resistance, improved cardiac output ARBs are Used in patients who cannot tolerate ACEIdue to cough.
51
Beta blockers:Epinephrine & nor epinephrine exert their
effects by binding to beta adrenergic in the heart and walls of the blood vessels.
β blockers bind to beta receptors thus obstructing the binding of catecholamines.
Hence β blockers reduce sympathetic of the heart and
blood vessels.Therefore ,beta blockers heart rate,
contractility and reduce blood pressure.
52
Mechanism of Action of Beta blockers
53
Vasodilators Ses the workload of the heart by dilating
peripheral vessels. By relaxing capacitance vessels(veins ,venules) ,
vasodilators decrease preload and volumes.Hydralazine predominantly affects arterioles ;
reduces arteriolar tone.Prazosin Balanced effect on both arterial
and venous circulation.Morphine venous return pain & anxiety.Sodium nitroprusside predominantly affects
arterioles.
54
NitratesNitrates such as NTG , Isosorbate , NTG
ointment predominantly dilate systemic veins.Nitrates are useful for patients with pulmonary
congestion ,dyspnoea symptoms
55
56
References:
Review articles from published journals.Principles of pharmacology by Sharma & Sharma.
57
Recommended